2025 fourth_quarter Filing
Q4Income
$80K
Filed
January 20, 2026
Lobbying Activities
Health IssuesView all
Issues related to compounding and counterfeit drugs.
Contacted:Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, White House Office
Medicare/MedicaidView all
Issues related to drug pricing and implementation of the Inflation Reduction Act. H.R. 1492, the Ensuring Pathways to Innovative Cures Act. Issues related to coverage of anti-obesity medications. Issues related to pharmacy benefit management reforms. Issues related to Most Favored Nation drug pricing.
Contacted:Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
Lobbyists (7)
GREG D'ANGELO
MARY BETH SAVARY TAYLOR
JEFF CHOUDHRY
BRETT BAKER